SCPX - Wutah pendapatan YoY sajrone 12 wulan kepungkur Scorpius Holdings, Inc.

Logo grafis Scorpius Holdings, Inc (SCPX)

The annual revenue growth rate (rolling period) on this GURU.Markets platform chart shows that the value has settled at . This trend is driven by the CDMO platform, which establishes long-term relationships with biologic drug developers. Operations are strictly regulated by FDA waste disposal standards. The integration of modern facilities makes Scorpius Holdings, Inc. (SCPX) an indispensable operational partner for the rapid release of pharmaceuticals.

Wutah dodolan YoY sajrone rolas wulan kepungkur Scorpius Holdings Inc. (SCPX): kanggo periode 04.07.2022 - 18.11.2026

Scorpius Holdings Inc. (SCPX) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:SCPX (Scorpius Holdings, Inc)
Produk dadi Scorpius Holdings

For Scorpius Holdings, Inc. (SCPX), the efficiency of the biopharma contract model depends directly on capacity utilization and the volume of the order book for clinical testing. By analyzing the current sales growth rate over a rolling 12-month period year-over-year, an investor assesses annual revenue dynamics, which allows for the differentiation of genuine business expansion from temporary demand spikes during periods of excess market liquidity.